|
The Scientist: NewsBlog:
HIV vaccine research: crisis of faith?
Posted by Bob Grant [Entry posted at 24th April 2008 08:27 PM GMT]
Rate this article
Return to Top comment: Why research is needed and where is the hope? by PRASANTA GHOSH [Comment posted 2008-04-29 08:47:50] While presently there is no vaccine against HIV, I believe that hope for the development of a vaccine is not yet lost. If the Merck?s experimental data are analyzed thread bare, one would be hopeful to find that several questions for which solutions can be found can now be addressed. Can we, for example, increase the antibody titer against the env proteins of HIV-I and concomitantly increase the CTL activity further? Is there any vector better than Adeno vector?
There can also be fall outs from the results of Merck?s trial. Presently, several kinds of highly active antiretroviral drugs are used to treat HIV patients; these drugs control the viral load and bring down viral numbers in the infected patients to the minimum. These synthetic chemical entities are used to combination to attack the virus in more than one of its path- ways, from infection to maturation and spread. The human endeavor has been to attack the virus by producing and deploying newer drugs (synthetics and biologically active substances) that act either by inhibiting attachment and fusion of the virus with the host cell, or inhibit the viral reverse transcriptase as also the agents that inhibit the HIV protease. Some other agents as viral assembly inhibitors and viral maturation inhibitors have also been used and investigated. While there has been some success to reduce the viral load in the infected by using these substances, none of the combinations have been successful as a cure. The combinations suited to individual patients are to be continued till the patients survive. Most of the drugs are considerably toxic; the recipients cannot often continue the drug combinations for longer periods. Sooner or later resistance to the used drug regimen develops and if the patients survive, they are to look for newer regimen of drugs for continuing treatment. In the mean time the immune system of the patients gets substantially damaged. In such circumstances, alternative agents that ensure maintaining almost non-detectable levels of HIV viral load in patients are very much needed to prolong their lives. Can we use substances like those of Merck or better ones in conjunction with anti-retroviral drugs in order to prolong the status of almost non-detectable levels of viral load in HIV patients for longer period than what is achievable presently? I think, such a regimen holds the potential of being the best bet for prolonging the life of the HIV patients under the existing state of scientific development in HIV globally before an effective but preventive HIV vaccine is discovered. Return to Top comment: I firmly believe that a vaccine against AIDS is possible, though if and only if there is a fundamental shift in paradigms by ROULETTE W SMITH [Comment posted 2008-04-28 20:09:37] I firmly believe that a vaccine against AIDS is possible, though if and only if there is a fundamental shift in paradigms. In several of my publications dating back to the mid-1980s, I cited a seemingly counterintuitive approach which is taught in ethological studies. My approach recognizes two overlooked issues in vaccine research targeting HIV. First, there always has been confusion regarding fundamental differences between HIV, as a lentivirus, and other retroviruses ? the oncoviruses and spumaviruses. For all practical purposes, it is unlikely that a vaccine can be crafted against HIV, though not AIDS per se. Second, AIDS is a misnomer; not all pathogens become opportunistic in HIV/AIDS. For the most part, only ?nascent? pathogens (including HIV itself ? and recursively) become opportunistic. It should be noted that an underlying logic involving Modus Tollendo Tollens can help clarify many of these issues. That logic also clarifies why the Henle-Koch postulates are irrelevant in HIV/AIDS; to wit, the opportunistic pathogens most often are not HIV.
The central question for the sciences is how to ?stop? the failed approaches and then to shift paradigms. Having worked in this field since 1979 (even before the first cases of GRIDS / AIDS were reported), I can attest to the challenges of getting investigators and scholars to see a ?bigger picture?. That bigger picture extends beyond the matter of vaccines for AIDS. For example, I had to formulate a theory of autotoxicity, autovirulence and context-specificity to explain high titers of acid-labile α-interferon in HIV/AIDS. The theory (in 1983) also explained the presence of EBV antigens in Kaposi?s sarcoma tissue, despite the subsequent discovery of a KSV8 ? another gamma herpesvirus. KSV8 investigators failed to appreciate the significance of a ~39% overlap in DNA sequences in EBV and KSV8. Most importantly, the theory provided the first concrete model for ?hit-and-run? and ?beneath-the-radar? infections associated with ubiquitous gamma herpesviruses. There is one final point which should not go unnoticed. Of the numerous international conferences on HIV/AIDS, I cannot recall any of those conferences wherein issues involving logic, methodology and the philosophy of sciences were encouraged or discussed. As a pun on Immanuel Kant?s ?A Critique of Pure Reason,? I addressed this matter head-on in 1983 at the 7th International Congress of Logic, Methodology and Philosophy of Science [Salzburg, AUSTRIA] 4:358-362. I titled my presentation, ?A Critique of Impure Reasoning in Biological Sciences.? Of course, there were no HIV/ AIDS scholars at the conference! Roulette Wm. Smith, Ph.D Institute for Postgraduate Interdisciplinary Studies P. O. Box 60846 Palo Alto, CA 94306-0846 USA E-Mail: najms@postgraduate-interdisciplinary-studies.org Return to Top comment: 20 years to an HIV vaccine is quite optimistic by Ellen Hunt [Comment posted 2008-04-28 15:25:04] I do not think an HIV vaccine that is significantly better than placebo will exist in 20 years. Prevention is everything. Comment on this blog |